-
Fingolimod (FTY720) for Trafficking Assays
2026-08-14
Fingolimod (FTY720) is more than an immunomodulatory agent for MS: it is a powerful experimental perturbation of lymphocyte positioning. This article explains how to use its S1P biology to interpret trafficking, CNS signaling, and emerging in vivo T-cell engineering assays without confusing migration effects with cytotoxicity.
-
Direct Mouse Genotyping Kit Plus for Lineage Studies
2026-08-13
The Direct Mouse Genotyping Kit Plus streamlines mouse genotyping for lineage-tracing, transgene detection, and gene knockout studies. Learn how direct PCR supports rigorous assay design while clarifying the distinction between genetic identity and macrophage phenotype.
-
Human SAN-Plexus Assembloids Model Pacemaker Maturation
2026-08-13
The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model innervation-associated pacemaker maturation. By integrating electrophysiology, organoid engineering, and human SAN spatial transcriptomics, the work identifies a prosaposin–GPR37 signaling program that links cardiac neurons with pacemaker development and provides a framework for studying conduction disorders.
-
HyperScript RT SuperMix for qPCR in URSA
2026-08-12
HyperScript RT SuperMix for qPCR can strengthen the mRNA-validation arm of URSA research by supporting structured RNA templates and limited input volumes. This article translates the miR-146a/b–IRAK1–NF-κB study into practical reverse-transcription and assay-design decisions, including an important distinction between mRNA and mature miRNA workflows.
-
Homoharringtonine: Designing Better Translation Assays
2026-08-12
Homoharringtonine is a cytotoxic alkaloid whose ribosome-directed mechanism creates both an antiviral opportunity and a major assay-design challenge. This guide connects leukemia research, cancer biology, and SARS-CoV-2 antiviral research through rigorous controls, orthogonal endpoints, and translational interpretation.
-
Quaternization Reprograms mRNA Lung Tropism
2026-08-11
Huang and colleagues showed that N-quaternization of the lipid-like compound tB-UC18 converts an mRNA carrier from spleen-biased to highly lung-selective biodistribution after intravenous administration. The study provides a relatively simple, ligand-free strategy for non-liver mRNA delivery, while also identifying important questions about charge state, immune-cell uptake, formulation stability, and therapeutic translation.
-
BCECF-AM Workflows for Intracellular pH
2026-08-11
BCECF-AM combines cell entry, esterase activation, and ratiometric fluorescence to make intracellular pH measurement practical in live-cell assays. This guide connects calibrated pH imaging with cytotoxicity, secretion, and plant-cell workflows while emphasizing controls, optimization, and interpretation limits.
-
Atrial Natriuretic Peptide: Assay Logic Beyond BP
2026-08-10
Atrial Natriuretic Peptide research is more informative when receptor signaling, renal physiology, and experimental causality are interpreted together. This guide connects ANP assay design with lessons from an adiponectin neuroinflammation study while defining practical limits for cardiovascular translation.
-
GW4064 for FXR Activation in Metabolic Research
2026-08-09
GW4064 is a selective non-steroidal FXR agonist for connecting receptor activation with bile acid metabolism, cholesterol and triglyceride regulation, and fibrotic signaling. This practical guide adapts findings from an LX-2 nickel oxide nanoparticle model into a reproducible workflow for pharmacological perturbation, pathway validation, and assay troubleshooting.
-
Autophagy–Metastasis Signature in Colorectal Cancer
2026-08-08
Bai et al. integrated autophagy- and liver metastasis-related transcriptional programs to create and validate a six-gene prognostic signature for colorectal cancer. Bulk and single-cell analyses linked high risk with immune dysfunction, SPP1-positive macrophage polarization, CD8+ T-cell exhaustion, and potential resistance to immunotherapy.
-
Dorsomorphin (Compound C) for AMPK Research
2026-08-07
Dorsomorphin (Compound C) enables reversible interrogation of AMPK activity while also revealing BMP/Smad-dependent effects in metabolic, endothelial, autophagy, and differentiation models. This workflow-focused guide connects the compound to a recent Ang II-treated HUVEC study and shows how to improve dosing, controls, readouts, and interpretation.
-
Dynasore (SKU A1605): Reliable Endocytosis Inhibition in Cel
2026-08-07
This article addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays by exploring how Dynasore (SKU A1605), a non-competitive dynamin GTPase inhibitor, provides reproducible and data-driven solutions for endocytosis research. Drawing on validated literature and practical laboratory scenarios, we offer evidence-based guidance for biomedical researchers and lab technicians seeking reliable assay outcomes and protocol optimization.
-
GTP Solution in mRNA Synthesis: Applied Workflows & Troubles
2026-08-06
Unlock high-yield, contamination-free mRNA synthesis with GTP Solution (100 mM), enabling advanced local therapies such as p21 mRNA-LNP for bladder cancer. This guide translates recent translational breakthroughs into actionable protocols, troubleshooting, and workflow enhancements for guanosine-5'-triphosphate–driven research.
-
Phosbind Acrylamide: Precision Phosphate-Binding Reagent in
2026-08-06
Phosbind Acrylamide bridges the gap between antibody-based and mobility-shift phosphorylation detection, enabling sensitive, reproducible analyses of protein phosphorylation states. With streamlined workflows and robust troubleshooting support, it empowers researchers to decode signaling cascades—no phospho-specific antibodies required.
-
Estradiol–Receptor–Autophagy Axis in Perimenopausal Organ Pr
2026-08-05
This study delineates how declining estradiol levels during perimenopause elevate cardiometabolic and renal risk, and demonstrates that estrogen’s protective effects are mediated by coordinated receptor signaling and autophagy. Integrating human cohort data, mouse models, and network pharmacology, it offers mechanistic guidance for precision hormone therapy strategies targeting multi-organ aging.